Alopecia News

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker at the Annual Meeting of The Menopause Society.

New results show that Elevai Labs’ exosome technology can successfully restore hair growth in combination with other hair treatments, the company announced in a press release.

After 1 year’s worth of hair regrowth among patients treated with baricitinib for severe alopecia areata, treatment withdrawal resulted in a loss of benefit for almost all patients, according to a study.

Gaining weight can raise the risk for atopic dermatitis and possibly other immune-mediated skin diseases in children, whereas losing weight can reduce this risk, according to a study.

Patients who followed a plant-based diet experienced hair growth with the addition of a daily vegan nutraceutical, according to a study.

Patients with alopecia treated with ritlecitinib reported high levels of satisfaction compared with those who received placebo, according to a study.

The first patients have been dosed in a phase 2a clinical trial of PP405 for the treatment of androgenetic alopecia, Pelage Pharmaceuticals announced in a press release.

Patients with alopecia areata who were treated with deuruxolitinib experienced significant hair regrowth and reported satisfaction, according to a study.